Search

Author/Creator Okuda, Inaha

1. A randomized dose-finding study demonstrating the efficacy and tolerability of albiglutide in Japanese patients with type 2 diabetes mellitus. (June 2014)

Authors:
Seino, Yutaka; Inagaki, Nobuya; Miyahara, Hajime; Okuda, Inaha; Bush, Mark; Ye, June; Holland, M. Claire; Johnson, Susan; Lewis, Eric; Nakajima, Hiromu
Journal:
Current medical research and opinion
Issue:
Volume 30:Number 6(2014:Jun.)
Page Start:
1095
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Albiglutide, a weekly GLP-1 receptor agonist, improves glycemic parameters in Japanese patients with type 2 diabetes over 1 year when added to single oral antidiabetic drugs. (4th March 2017)

Authors:
Okuda, Inaha; Wilson, Timothy H.; Yue, Lin; Nakajima, Hiromu; Carr, Molly C.; Tsuboi, Maho; Nino, Antonio; Seino, Yutaka
Journal:
Current medical research and opinion
Issue:
Volume 33:Number 3(2017)
Page Start:
431
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Weekly glucagon‐like peptide‐1 receptor agonist albiglutide as monotherapy improves glycemic parameters in Japanese patients with type 2 diabetes mellitus: A randomized, double‐blind, placebo‐controlled study. Issue 3 (3rd November 2017)

Authors:
Nino, Antonio; Okuda, Inaha; Wilson, Timothy H; Yue, Lynn; Nakajima, Hiromu; Tsuboi, Maho; Carr, Molly C; Seino, Yutaka
Journal:
Journal of diabetes investigation
Issue:
Volume 9:Issue 3(2018)
Page Start:
558
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗